[
  {
    "ts": "2025-12-12T15:35:00+00:00",
    "headline": "The Best Turnaround Stock to Invest $1,000 in Right Now",
    "summary": "Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term.",
    "url": "https://www.fool.com/investing/2025/12/12/the-best-turnaround-stock-to-invest-1000-in-right/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "0f59533b-1d63-3074-888c-8f4d3033df44",
      "content": {
        "id": "0f59533b-1d63-3074-888c-8f4d3033df44",
        "contentType": "STORY",
        "title": "The Best Turnaround Stock to Invest $1,000 in Right Now",
        "description": "",
        "summary": "Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you think long term.",
        "pubDate": "2025-12-12T15:35:00Z",
        "displayTime": "2025-12-12T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3",
          "originalWidth": 1200,
          "originalHeight": 799,
          "caption": "A die with the words buy, sell, and hold on it sitting next to money.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nROAVHH7jxnTMBHKkEGukg--~B/aD03OTk7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3.cf.webp",
              "width": 1200,
              "height": 799,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O8FyoDk8MdyUHcAKT3_qLA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b47511a233a3647268887a15fa81abd3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/12/the-best-turnaround-stock-to-invest-1000-in-right/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-turnaround-stock-invest-1-153500040.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T17:00:00+00:00",
    "headline": "Pfizer Declares First-Quarter 2026 Dividend",
    "summary": "NEW YORK, December 12, 2025--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 first-quarter 2026 dividend on the company’s common stock, payable March 6, 2026, to holders of the Common Stock of record at the close of business on January 23, 2026. The first-quarter 2026 cash dividend will be the 349th consecutive quarterly dividend paid by Pfizer.",
    "url": "https://finance.yahoo.com/news/pfizer-declares-first-quarter-2026-170000415.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "fb490470-a6a7-319f-ae7f-970eb0fa05b8",
      "content": {
        "id": "fb490470-a6a7-319f-ae7f-970eb0fa05b8",
        "contentType": "STORY",
        "title": "Pfizer Declares First-Quarter 2026 Dividend",
        "description": "",
        "summary": "NEW YORK, December 12, 2025--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 first-quarter 2026 dividend on the company’s common stock, payable March 6, 2026, to holders of the Common Stock of record at the close of business on January 23, 2026. The first-quarter 2026 cash dividend will be the 349th consecutive quarterly dividend paid by Pfizer.",
        "pubDate": "2025-12-12T17:00:00Z",
        "displayTime": "2025-12-12T17:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/474bc14c114f4c2a63d811ef4c62f349",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T6xsMqTmLNy6zPrWidtCpQ--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/474bc14c114f4c2a63d811ef4c62f349.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/55c3I9jynENoW80zC6E1_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/474bc14c114f4c2a63d811ef4c62f349.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-declares-first-quarter-2026-170000415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-declares-first-quarter-2026-170000415.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-12T16:52:00+00:00",
    "headline": "Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.",
    "summary": "Keep your expectations in check.",
    "url": "https://www.fool.com/investing/2025/12/12/pfizer-is-struggling-to-replace-its-covid-revenue/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f92a52e4-5a8d-3f8b-a533-a5e1e0892ed7",
      "content": {
        "id": "f92a52e4-5a8d-3f8b-a533-a5e1e0892ed7",
        "contentType": "STORY",
        "title": "Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.",
        "description": "",
        "summary": "Keep your expectations in check.",
        "pubDate": "2025-12-12T16:52:00Z",
        "displayTime": "2025-12-12T16:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/cf29f3b02f1fe832f3059d74853d070e",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "Person raising both fists in the air. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tKg8zI1kIs8CIepSJM.tnA--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/cf29f3b02f1fe832f3059d74853d070e.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cj3AbLedOHvF4znqbGpWeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/cf29f3b02f1fe832f3059d74853d070e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/12/pfizer-is-struggling-to-replace-its-covid-revenue/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-still-struggling-replace-covid-165200032.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]